Symposia
Treatment - CBT
Laurie Compere, Ph.D. (she/her/hers)
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Greg J. Siegle, Ph.D. (he/him/his)
Professor
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
Emily Riley, B.S. (she/her/hers)
Research Specialist
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Sair Lazzaro, B.S. (they/them/theirs)
Art Therapist
George Washington University
Washington, District of Columbia, United States
Marlene V. Strege, Ph.D. (she/her/hers)
Post-doctoral Scholar
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
Elizabeth Pacoe, Ph.D. (she/her/hers)
Therapist
Tripp Psychiatry
Pittsburgh, Pennsylvania, United States
Gia Canovali, LCSW (she/her/hers)
Senior Therapist
The Center for OCD and Anxiety
Monroeville, Pennsylvania, United States
Scott Barb, LSW (he/him/his)
Research Coordinator
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Theodore Huppert, Ph.D. (he/him/his)
Research Associate Professor
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Kymberly Young, Ph.D. (she/her/hers)
Associate Professor
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Background: CBT is a standard treatment for major depressive disorder (MDD) and one of the predictors of CBT’s efficacy is amygdala reactivity to positive information. However, participants suffering from MDD exhibit less amygdala activity to positive information. Therefore, we used an amygdala real-time fMRI neurofeedback (rt-fMRI-nf) intervention to train participants with MDD to enhance their amygdala activity while recalling positive autobiographical memories (AM) prior to CBT.
Methods: In a double-blind, placebo-controlled, randomized clinical trial, 35 adults with MDD received two sessions of rt-fMRI-nf training to increase their amygdala (experimental group, N=16) or parietal (control group, N=19) responses during positive AMs recall before receiving 10 sessions of CBT. Participants were recruited from the community via advertisements and through the Pitt+Me research participant registry and the sample strongly oversampled white women. Depressive symptomatology was self-reported between rt-fMRI-nf sessions, the first three, 9th, and 10th sessions of CBT, and at 6 months and 1-year follow-up.
Results: Participants in the experimental group showed decreased symptomatology and higher remission rates at 6 months and 1-year follow-up, and, analysis of CBT content highlighted more focus on positive thinking and behaviors in comparison to the control group.
Conclusions: Combination of amygdala rt-fMRI-nf and CBT results in sustained clinical changes and long-lasting clinical improvement, potentially by increasing focus on positive cognitions.